Becton strengthens needle pact with Med-Design:
This article was originally published in Clinica
Becton Dickinson has signed a further development agreement with Ventura, California-based Med-Design. The agreement means that Med-Design will assist in obtaining market release of Becton Dickinson's safety IV catheter. This includes tasks in support of the FDA filing for the product, including a protocol for additional design, development, testing or manufacturing. Med-Design had earlier obtained a 510(k) clearance for a previous version of the device. This adds to the agreement which gave Becton the exclusive worldwide rights to five infusion therapy and blood collection safety devices designed by Med-Design.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.